RecruitingNot ApplicableNCT06111599
Thermovision-controlled Lumbar Sympathetic Blockade in Chronic Limb-threatening Ischemia Treatment
Sponsor
EPC Education s.r.o.
Enrollment
60 participants
Start Date
Oct 22, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Thermovision-controlled lumbar sympathetic blockade in chronic limb-threatening ischemia treatment
Eligibility
Min Age: 20 YearsMax Age: 80 Years
Inclusion Criteria2
- Chronic limb-threatening ischemia-Patients with chronic leg pain for at least 6 months with intensity (VAS >=5)
- those who (only if a signature was obtainable), or whose legal guardian,fully understood the clinical trial -details and signed the informed consent form
Exclusion Criteria4
- Chronic Venous Insufficiency
- women with positive a pregnancy tests before the trial or who planned to become pregnant within the following 3 years
- other patients viewed as inappropriate by the staff
- disagreement with participation in the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURElumbar sympathetic blockade
Skiascopic-guided lumbar sympathetic blockade with the administration of local anesthetic
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06111599
Related Trials
Intravascular Ultrasound for Peripheral Artery Disease Revascularization
NCT069792842 locations
Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study
NCT0614965039 locations
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NCT0531316530 locations
Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia
NCT073528003 locations
Durg Coated Balloon Angioplasty in Infrapopliteal Lesions
NCT0562009510 locations